Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

September 9, 2024

Femasys received U.S. FDA clearance to market FemChec, a diagnostic solution for evaluating fallopian tube patency.